TIME-LONG-TERM

NTR2452 📎

Regimen

Experimental
minimally invasive esophagectomy (MIE)
Control
open transthoracic esophagectomy

Population

Resectable intrathoracic esophageal cancer including Siewert I GEJ, 3-year follow-up

Key finding

3y OS 40.4% (open) vs 50.5% (MIE), HR 0.88 (NS); 3y DFS 35.9% vs 40.2%, HR 0.69 (NS). Oncologic equivalence confirmed.

Source: PMID 28187044

Timeline

    Guideline citations

    • NCCN ESOPHAGEAL (p.50)